Oclacitinib
708 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
708
Total Reports
48
Deaths Reported
680.0%
Death Rate
Active Ingredients
Oclacitinib
Administration Routes
OralUnknownIntragastric
Species Affected
Dog 655
Unknown 50
Cat 2
Horse 1
Most Affected Breeds
Retriever - Labrador 64
Unknown 56
Shih Tzu 40
Crossbred Canine/dog 33
Shepherd Dog - German 30
Chihuahua 27
Pit Bull 25
Beagle 22
Terrier - Yorkshire 22
Retriever - Golden 22
Most Reported Reactions
Vomiting 109
Lack of efficacy - NOS 80
Diarrhoea 76
Lethargy (see also Central nervous system depression in 'Neurological') 57
Not eating 42
Pruritus 36
Anorexia 35
Lethargy (see also Central nervous system depression in Neurological) 35
Behavioural disorder NOS 34
Elevated blood urea nitrogen (BUN) 33
Elevated serum alkaline phosphatase (SAP) 33
Decreased appetite 32
Outcome Breakdown
Outcome Unknown
290 (44.1%)
Recovered/Normal
194 (29.5%)
Ongoing
105 (16.0%)
Euthanized
29 (4.4%)
Recovered with Sequela
21 (3.2%)
Died
19 (2.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.